EZH2 and neoplasm: In our study, we found that most cancer driver genes are specifically expressed in tumor tissue, and we constructed a four-mRNA prognostic signature (ETV5, EZH2, PABPC1, ZCRB1) that has higher predictive power than other clinical features.